Nabulsi Azmi 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Purchase
Common Stock
2022-05-16$8.16/sh+20,000$163,288→ 785,700 total(indirect: By Trust)
Holdings
- 21,378
Common Stock
- 843.42(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $8.43. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.